Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 556

1.

Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies.

Ding WY, Harrison S, Gupta D, Lip GYH, Lane DA.

Front Med (Lausanne). 2020 Feb 21;7:54. doi: 10.3389/fmed.2020.00054. eCollection 2020. Review.

2.

The potential for photoplethysmographic (PPG)-based smart devices in atrial fibrillation detection.

Harrison SL, Lane DA, Guo Y, Lip GYH.

Expert Rev Med Devices. 2020 Mar 12:1-3. doi: 10.1080/17434440.2020.1740085. [Epub ahead of print] No abstract available.

PMID:
32138559
3.

The Compelling Issue of Nonvitamin K Antagonist Oral Anticoagulant Adherence in Atrial Fibrillation Patients: A Systematic Need for New Strategies.

Proietti M, Lane DA.

Thromb Haemost. 2020 Mar;120(3):369-371. doi: 10.1055/s-0040-1702231. Epub 2020 Mar 5. No abstract available.

PMID:
32135563
4.

Peri-procedural management, implantation feasibility, and short-term outcomes in patients undergoing implantation of leadless pacemakers: European Snapshot Survey.

Lenarczyk R, Boveda S, Mansourati J, Russo V, Marijon E, Lane DA, Dagres N, Potpara TS.

Europace. 2020 Feb 19. pii: euaa023. doi: 10.1093/europace/euaa023. [Epub ahead of print]

PMID:
32073116
5.

Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group.

Seligman WH, Das-Gupta Z, Jobi-Odeneye AO, Arbelo E, Banerjee A, Bollmann A, Caffrey-Armstrong B, Cehic DA, Corbalan R, Collins M, Dandamudi G, Dorairaj P, Fay M, Van Gelder IC, Goto S, Granger CB, Gyorgy B, Healey JS, Hendriks JM, Hills MT, Hobbs FDR, Huisman MV, Koplan KE, Lane DA, Lewis WR, Lobban T, Steinberg BA, McLeod CJ, Moseley S, Timmis A, Yutao G, Camm AJ.

Eur Heart J. 2020 Mar 7;41(10):1132-1140. doi: 10.1093/eurheartj/ehz871.

6.

Etiologic workup in cases of cryptogenic stroke: protocol for a systematic review and comparison of international clinical practice guidelines.

Bray EP, McMahon NE, Bangee M, Al-Khalidi AH, Benedetto V, Chauhan U, Clegg AJ, Georgiou RF, Gibson J, Lane DA, Lip GYH, Lightbody E, Sekhar A, Chatterjee K, Watkins CL.

Syst Rev. 2019 Dec 17;8(1):331. doi: 10.1186/s13643-019-1247-6.

7.

Reducing risk of adverse cardiovascular and renal outcomes for patients with atrial fibrillation and type 2 diabetes.

Harrison SL, Lane DA, Lip GYH.

Eur J Heart Fail. 2020 Jan;22(1):136-138. doi: 10.1002/ejhf.1685. Epub 2019 Dec 9. No abstract available.

PMID:
31820530
8.

Alpha-synuclein is strategically positioned for afferent modulation of midbrain dopamine neurons and is essential for cocaine preference.

Trubetckaia O, Lane AE, Qian L, Zhou P, Lane DA.

Commun Biol. 2019 Nov 15;2:418. doi: 10.1038/s42003-019-0651-8. eCollection 2019.

9.

Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation.

Huppertz N, Lip GYH, Lane DA.

Clin Res Cardiol. 2019 Nov 7. doi: 10.1007/s00392-019-01567-y. [Epub ahead of print]

PMID:
31701215
10.

Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries.

Miyazawa K, Ogawa H, Mazurek M, Shantsila E, Lane DA, Wolff A, Akao M, Lip GYH.

Circ J. 2019 Nov 25;83(12):2434-2442. doi: 10.1253/circj.CJ-19-0546. Epub 2019 Nov 6.

11.

Warfarin Therapy and Improved Anticoagulation Control by Patient Self-Management.

Ritchie LA, Penson PE, Lane DA.

Thromb Haemost. 2019 Oct;19(10):1550-1552. doi: 10.1055/s-0039-1696982. Epub 2019 Sep 29. No abstract available.

PMID:
31564055
12.

Global Use of Idarucizumab in Clinical Practice: Outcomes of the RE-VECTO Surveillance Program.

Fanikos J, Murwin D, Gruenenfelder F, Tartakovsky I, França LR, Reilly PA, Kermer P, Wowern FV, Lane DA, Butcher K.

Thromb Haemost. 2020 Jan;120(1):27-35. doi: 10.1055/s-0039-1695771. Epub 2019 Aug 30.

13.

Partial rescue of naturally occurring active site factor X variants through decreased inhibition by tissue factor pathway inhibitor and antithrombin.

Ahnström J, Gierula M, Temenu J, Laffan MA, Lane DA.

J Thromb Haemost. 2020 Jan;18(1):136-150. doi: 10.1111/jth.14627. Epub 2019 Sep 20.

PMID:
31466141
14.

Integrated care for the management of atrial fibrillation: what are the key components and important outcomes?

Lane DA, Lip GYH.

Europace. 2019 Aug 7. pii: euz211. doi: 10.1093/europace/euz211. [Epub ahead of print] No abstract available.

PMID:
31390468
15.

The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.

Gierula M, Salles-Crawley II, Santamaria S, Teraz-Orosz A, Crawley JTB, Lane DA, Ahnström J.

J Thromb Haemost. 2019 Dec;17(12):2056-2068. doi: 10.1111/jth.14594. Epub 2019 Aug 9.

16.

Exosites in Hypervariable Loops of ADAMTS Spacer Domains control Substrate Recognition and Proteolysis.

Santamaria S, Yamamoto K, Teraz-Orosz A, Koch C, Apte SS, de Groot R, Lane DA, Ahnström J.

Sci Rep. 2019 Jul 29;9(1):10914. doi: 10.1038/s41598-019-47494-w.

17.

Defective fibrin deposition and thrombus stability in Bambi-/- mice are mediated by elevated anticoagulant function.

Crawley JTB, Zalli A, Monkman JH, Petri A, Lane DA, Ahnstrom J, Salles-Crawley II.

J Thromb Haemost. 2019 Nov;17(11):1935-1949. doi: 10.1111/jth.14593. Epub 2019 Aug 26.

18.

Chronic adolescent exposure to ∆9-tetrahydrocannabinol decreases NMDA current and extrasynaptic plasmalemmal density of NMDA GluN1 subunits in the prelimbic cortex of adult male mice.

Pickel VM, Bourie F, Chan J, Mackie K, Lane DA, Wang G.

Neuropsychopharmacology. 2020 Jan;45(2):374-383. doi: 10.1038/s41386-019-0466-9. Epub 2019 Jul 19.

PMID:
31323660
19.

Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey.

Lane DA, Meyerhoff J, Rohner U, Lip GYH.

TH Open. 2018 Jul 5;2(3):e233-e241. doi: 10.1055/s-0038-1666803. eCollection 2018 Jul.

20.

Educational Impact on Apixaban Adherence in Atrial Fibrillation (the AEGEAN STUDY): A Randomized Clinical Trial.

Montalescot G, Brotons C, Cosyns B, Crijns HJ, D'Angelo A, Drouet L, Eberli F, Lane DA, Besse B, Chan A, Vicaut E, Darius H; AEGEAN Study Investigators.

Am J Cardiovasc Drugs. 2020 Feb;20(1):61-71. doi: 10.1007/s40256-019-00356-2.

21.

Psychotropic drug use following venous thromboembolism versus diabetes mellitus in adolescence or young adulthood: a Danish nationwide cohort study.

Højen AA, Søgaard M, Melgaard L, Lane DA, Sørensen EE, Goldhaber SZ, Larsen TB.

BMJ Open. 2019 May 14;9(5):e026159. doi: 10.1136/bmjopen-2018-026159.

22.

Anticoagulation for Atrial Fibrillation in Older Adults-Using Big Data for Big Questions.

Quinn TJ, Lane DA.

Thromb Haemost. 2019 Jun;119(6):855-857. doi: 10.1055/s-0039-1688482. Epub 2019 Apr 30. No abstract available.

PMID:
31041792
23.

Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines.

Proietti M, Lane DA, Boriani G, Lip GYH.

Can J Cardiol. 2019 May;35(5):619-633. doi: 10.1016/j.cjca.2019.02.009. Epub 2019 Feb 21. Review.

PMID:
31030864
24.

Mobile Health (mHealth) technology for improved screening, patient involvement and optimising integrated care in atrial fibrillation: The mAFA (mAF-App) II randomised trial.

Guo Y, Lane DA, Wang L, Chen Y, Lip GYH; mAF-App II Trial investigators.

Int J Clin Pract. 2019 Jul;73(7):e13352. doi: 10.1111/ijcp.13352. Epub 2019 Jun 3.

PMID:
31002434
25.

The Liverpool Centre for Cardiovascular Science.

Lip GYH, Lane DA.

Eur Heart J. 2019 Mar 21;40(12):957-958. doi: 10.1093/eurheartj/ehz107. No abstract available.

PMID:
30896770
26.

Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS).

Arnar DO, Mairesse GH, Boriani G, Calkins H, Chin A, Coats A, Deharo JC, Svendsen JH, Heidbüchel H, Isa R, Kalman JM, Lane DA, Louw R, Lip GYH, Maury P, Potpara T, Sacher F, Sanders P, Varma N, Fauchier L; ESC Scientific Document Group ; EHRA Scientific Documents Committee .

Europace. 2019 Mar 18. pii: euz046. doi: 10.1093/europace/euz046. [Epub ahead of print]

PMID:
30882141
27.

Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey.

Lane DA, Dagres N, Dan GA, García Seara J, Iliodromitis K, Lenarczyk R, Lip GYH, Mansourati J, Marín F, Scherr D, Potpara TS.

Europace. 2019 Jul 1;21(7):1116-1125. doi: 10.1093/europace/euz033.

PMID:
30874724
28.

Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week.

Diener HC, Hart RG, Koudstaal PJ, Lane DA, Lip GYH.

J Am Coll Cardiol. 2019 Feb 12;73(5):612-619. doi: 10.1016/j.jacc.2018.10.077. Review.

29.

Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review.

Pritchett RV, Bem D, Turner GM, Thomas GN, Clarke JL, Fellows R, Lane DA, Jolly K.

Thromb Haemost. 2019 Feb;119(2):294-307. doi: 10.1055/s-0038-1676835. Epub 2019 Jan 22.

PMID:
30669165
30.

The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.

Newnham M, South K, Bleda M, Auger WR, Barberà JA, Bogaard H, Bunclark K, Cannon JE, Delcroix M, Hadinnapola C, Howard LS, Jenkins D, Mayer E, Ng C, Rhodes CJ, Screaton N, Sheares K, Simpson MA, Southwood M, Su L, Taboada D, Traylor M, Trembath RC, Villar SS, Wilkins MR, Wharton J, Gräf S, Pepke-Zaba J, Laffan M, Lane DA, Morrell NW, Toshner M.

Eur Respir J. 2019 Mar 28;53(3). pii: 1801805. doi: 10.1183/13993003.01805-2018. Print 2019 Mar.

31.

Effectiveness of Cognitive Behavioral Therapy for Depression and Anxiety in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis.

Reavell J, Hopkinson M, Clarkesmith D, Lane DA.

Psychosom Med. 2018 Oct;80(8):742-753. doi: 10.1097/PSY.0000000000000626.

PMID:
30281027
32.

Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway.

Proietti M, Romiti GF, Olshansky B, Lane DA, Lip GYH.

Am J Med. 2018 Nov;131(11):1359-1366.e6. doi: 10.1016/j.amjmed.2018.06.012. Epub 2018 Aug 26.

PMID:
30153428
33.

Enhanced activity of an ADAMTS-13 variant (R568K/F592Y/R660K/Y661F/Y665F) against platelet agglutination in vitro and in a murine model of acute ischemic stroke.

South K, Denorme F, Salles-Crawley II, De Meyer SF, Lane DA.

J Thromb Haemost. 2018 Nov;16(11):2289-2299. doi: 10.1111/jth.14275. Epub 2018 Oct 24.

34.

Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.

Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, Lane DA, Ruff CT, Turakhia M, Werring D, Patel S, Moores L.

Chest. 2018 Nov;154(5):1121-1201. doi: 10.1016/j.chest.2018.07.040. Epub 2018 Aug 22.

PMID:
30144419
35.

Qualitative exploration of the effect of a television soap opera storyline on women with experience of postpartum psychosis.

Roberts L, Berrisford G, Heron J, Jones L, Jones I, Dolman C, Lane DA.

BJPsych Open. 2018 Mar 19;4(2):75-82. doi: 10.1192/bjo.2018.9. eCollection 2018 Mar.

36.

Use of NOACs in the Peri-Operative Management of Patients with Atrial Fibrillation: To Stop, Bridge or Continue?

Proietti M, Lane DA.

Thromb Haemost. 2018 Jul;118(7):1123-1126. doi: 10.1055/s-0038-1661370. Epub 2018 Jul 2. No abstract available.

PMID:
29966164
37.

Endogenous Protection from Ischemic Brain Injury by Preconditioned Monocytes.

Garcia-Bonilla L, Brea D, Benakis C, Lane DA, Murphy M, Moore J, Racchumi G, Jiang X, Iadecola C, Anrather J.

J Neurosci. 2018 Jul 25;38(30):6722-6736. doi: 10.1523/JNEUROSCI.0324-18.2018. Epub 2018 Jun 26.

38.

Guideline-adherent secondary prevention post-acute coronary syndromes: the importance of patient uptake and persistence.

Székely O, Lane DA, Lip GYH.

Eur Heart J. 2018 Jul 1;39(25):2365-2367. doi: 10.1093/eurheartj/ehy308. No abstract available.

PMID:
29878099
39.

Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries.

Proietti M, Laroche C, Nieuwlaat R, Crijns HJGM, Maggioni AP, Lane DA, Boriani G, Lip GYH; EORP-AF General Pilot Registry; Euro Heart Survey on AF Investigators.

Eur J Intern Med. 2018 Sep;55:28-34. doi: 10.1016/j.ejim.2018.05.016. Epub 2018 May 16.

PMID:
29778588
40.

Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis.

Lane DA, Meyerhoff J, Rohner U, Lip GYH.

Clin Cardiol. 2018 Jun;41(6):855-861. doi: 10.1002/clc.22971. Epub 2018 Jun 12.

41.

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice?

Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Márquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK, Bautista-Vargas WF, Chiang CE, Cuesta A, Dan GA, Frankel DS, Guo Y, Hatala R, Lee YS, Murakawa Y, Pellegrini CN, Pinho C, Milan DJ, Morin DP, Nadalin E, Ntaios G, Prabhu MA, Proietti M, Rivard L, Valentino M, Shantsila A.

J Arrhythm. 2018 Mar 23;34(2):99-123. doi: 10.1002/joa3.12050. eCollection 2018 Apr. No abstract available.

42.

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?

Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Márquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK.

Heart Rhythm. 2018 Jun;15(6):e37-e60. doi: 10.1016/j.hrthm.2018.03.005. Epub 2018 Mar 18. No abstract available.

PMID:
29563045
43.

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?

Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Márquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK; ESC Scientific Document Group.

Europace. 2018 Sep 1;20(9):1399-1421. doi: 10.1093/europace/euy046. No abstract available.

44.

Cognitive Behavioral Therapy for Depression, Anxiety, and Stress in Caregivers of Dementia Patients: A Systematic Review and Meta-Analysis.

Hopkinson MD, Reavell J, Lane DA, Mallikarjun P.

Gerontologist. 2019 Jul 16;59(4):e343-e362. doi: 10.1093/geront/gnx217.

PMID:
29529290
45.

Epidemiology of atrial fibrillation.

Zulkifly H, Lip GYH, Lane DA.

Int J Clin Pract. 2018 Mar;72(3):e13070. doi: 10.1111/ijcp.13070. Epub 2018 Mar 1.

PMID:
29493854
46.

Biphasic activation of complement and fibrinolysis during the human nasal allergic response.

Thwaites RS, Gunawardana NC, Broich V, Mann EH, Ahnström J, Campbell GA, Lindsley S, Singh N, Tunstall T, Lane DA, Openshaw PJ, Hawrylowicz CM, Hansel TT.

J Allergy Clin Immunol. 2018 May;141(5):1892-1895.e6. doi: 10.1016/j.jaci.2018.01.022. Epub 2018 Feb 7. No abstract available.

47.

A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von Willebrand factor.

South K, Freitas MO, Lane DA.

J Biol Chem. 2018 Jan 26;293(4):1149-1150. doi: 10.1074/jbc.AAC117.001638. Epub 2018 Jan 26. No abstract available.

48.

Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation.

Lip GYH, Lane DA, Potpara TS.

Eur Heart J. 2018 Apr 21;39(16):1404-1406. doi: 10.1093/eurheartj/ehx807. No abstract available.

PMID:
29325061
49.

Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference.

Kotecha D, Breithardt G, Camm AJ, Lip GYH, Schotten U, Ahlsson A, Arnar D, Atar D, Auricchio A, Bax J, Benussi S, Blomstrom-Lundqvist C, Borggrefe M, Boriani G, Brandes A, Calkins H, Casadei B, Castellá M, Chua W, Crijns H, Dobrev D, Fabritz L, Feuring M, Freedman B, Gerth A, Goette A, Guasch E, Haase D, Hatem S, Haeusler KG, Heidbuchel H, Hendriks J, Hunter C, Kääb S, Kespohl S, Landmesser U, Lane DA, Lewalter T, Mont L, Nabauer M, Nielsen JC, Oeff M, Oldgren J, Oto A, Pison L, Potpara T, Ravens U, Richard-Lordereau I, Rienstra M, Savelieva I, Schnabel R, Sinner MF, Sommer P, Themistoclakis S, Van Gelder IC, Vardas PE, Verma A, Wakili R, Weber E, Werring D, Willems S, Ziegler A, Hindricks G, Kirchhof P.

Europace. 2018 Mar 1;20(3):395-407. doi: 10.1093/europace/eux318.

50.

Individual depressive symptoms and all-cause mortality In 6673 patients with myocardial infarction: Heterogeneity across age and sex subgroups.

de Miranda Azevedo R, Roest AM, Carney RM, Freedland KE, Lane DA, Parakh K, de Jonge P, Denollet J.

J Affect Disord. 2018 Mar 1;228:178-185. doi: 10.1016/j.jad.2017.11.025. Epub 2017 Nov 16.

PMID:
29253684

Supplemental Content

Support Center